Side Effects Involving the Heart in Women With Breast Cancer Receiving Doxorubicin and Trastuzumab
- Status
- COMPLETED
- Phase
- N/A
Clinical Trials Related to Trastuzumab
Related studies linked through entity extraction aliases.
Open Label Trial of INCB07839 to Determine Effect and Safety of INCB007839 Plus Trastuzumab in HER2 Positive Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Open Label Trial of Perifosine in Patients Currently Being Treated on Perifosine Trials in Solid Tumors or Multiple Myeloma
- Status
- COMPLETED
- Phase
- NA
Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Trastuzumab Versus Lapatinib as Neoadjuvant Treatment for Her2+ Patients
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Pregnancy and Pregnancy Outcomes in Women With Breast Cancer Treated With Trastuzumab, Pertuzumab in Combination With Trastuzumab, or Ado-Trastuzumab Emtansine
- Status
- COMPLETED
- Phase
- N/A
6 Weeks Treatment of Locally Advanced Breast Cancer With BIBW 2992 (Afatinib) or Lapatinib or Trastuzumab
- Status
- COMPLETED
- Phase
- PHASE2
Agatolimod and Trastuzumab in Treating Patients With Locally Advanced or Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Neoadjuvant Ixabepilone/Carboplatin/Trastuzumab in HER2-Positive Locally Advanced Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel, Carboplatin, Trastuzumab, and Lapatinib in Treating Patients With Early Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in ErbB2 (HER2) Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of IPI-504 With Trastuzumab Pretreated, Locally Advanced or Metastatic HER2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Phase 2 Study of Trastuzumab and Etoposide for Her2 Positive Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trial of the Combination of Intravenous Alvespimycin (KOS-1022), Trastuzumab With or Without Paclitaxel in Patients With Advanced Solid Tumor Malignancies or Her2 Positive Metastatic Breast Cancer Who Have Previously Failed Trastuzumab Therapy
- Status
- COMPLETED
- Phase
- PHASE1
Trastuzumab in Treating Older Women With Early-Stage Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Chemotherapeutic Agents in Brain/Breast
- Status
- COMPLETED
- Phase
- N/A
A Trial l of Panobinostat Given in Combination With Trastuzumab and Paclitaxel in Adult Female Patients With HER2 Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Paclitaxel and Trastuzumab With or Without Lapatinib in Treating Patients With Stage II or Stage III Breast Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE3
Docetaxel, Carboplatin, and Trastuzumab and/or Lapatinib in Treating Women With Stage I, Stage II, or Stage III Breast Cancer That Can Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2